Skip to main content

“We can help to predict the negative effects of drugs that have not yet been studied”

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

Patrick Aloy, ICREA researcher and group leader of the Structural Bioinformatics and Network Biology group at IRB Barcelona, has been interviewed on the Radio 4 programme “L’Observatori” (The Observatory) about his work on the development of a model that predicts the positive or negative effects that chemical compounds fragments may have on health. Currently including data for 20% of diseases, the model will allow the design of safer drugs, the identification of new uses for drugs already on the market, and the detection of associations between diseases.

Listen to the interview on Radio 4 (in Catalan, minute 16:10 – 23:04)

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).